ARCHIVED: This Practice Note has been archived and is not maintained. This tracker is intended to be used to track key developments, legislation, guidance and other sources of interest relating to coronavirus (COVID-19) and judicial review. It is designed to provide an easy reference point for relevant content for lawyers during the COVID-19 outbreak. Practice Directions col style="width: 33%;"> Development Date Find out more Practice Direction 51ZA—Extension of time limits and clarification of Practice Direction 51Y 2 April 2020 New Practice Direction 51ZA—Extension of time limits and clarification of Practice Direction 51Y On 1 April 2020, the Ministry of Justice signed the 118th update—practice directions amendments, which introduces a further coronavirus pandemic related practice direction.Practice Direction 51ZA, concerns extensions of time limits and came into force on 2 April 2020. It also provides clarification of Practice Direction 51Y, which came into force on 25 March 2020.See News Analysis: Coronavirus (COVID–19)—new Practice Direction 51ZA (118th update)—2 April 2020. Practice Direction 51Y—Video or audio hearings during coronavirus pandemic 25 March 2020 New Practice Direction 51Y—Video or audio

ARCHIVED: This Practice Note was archived in April 2022 and is not maintained. Up to date information on the financial support given by the government during the COVID-19 pandemic can be found on the British Business Bank website. Scope This Practice Note, produced in partnership with James Collis and John Alderton of Squire Patton Boggs LLP, summarises the various schemes and support measures introduced by the UK government to assist businesses in their response to the COVID-19 pandemic. It may be easier to read this Practice Note by downloading a copy using the button on the top left and changing the page layout to landscape. Financing Facility Support What help is available? What does the help entail? Which companies are eligible? What are the criteria (if any) for applying? How to apply Availability? Recovery Loan Scheme (RLS) • This replaced the previous coronavirus (COVID-19) loan schemes when they closed• The loans are available through a network of accredited lenders• Ensures businesses of any size can continue

Access to the Coronavirus Job Retention Scheme (CJRS) and the Self-Employment Income Support Scheme (SEISS) will be via HMRC. The CJRS is a scheme designed for employers whose operations have been severely affected by coronavirus to claim reimbursement for wages paid to employees who have been placed on furlough. Eligible employers will need to submit information to HMRC about their employees that have been furloughed, and their earnings, through an online portal specifically created for this purpose. For further information about which employers are eligible for the scheme, see: • Practice Note: Coronavirus Job Retention Scheme (original version to 30 June 2020) [Archived] • HMRC guidance: Guidance for employers: Claim for your employees' wages through the coronavirus job retention scheme The SEISS scheme applies only to those individuals who are self-employed or members of a partnership. Other relevant criteria include that they must have a trading profit of less than £50,000 in 2018-19

ARCHIVED: This Practice Note has been archived and is not maintained. This Practice Note tracks the developments and updates on coronavirus (COVID-19) that relate to the life sciences sector in the EU. For coronavirus developments of interest to the life sciences sector in the UK, see Practice Note: Coronavirus (COVID-19)—UK life sciences tracker [Archived]. Jump to: • Research and development of medicines and vaccines • IP waiver • Clinical trials • Regulation of medical devices • Regulation of vaccines, medicinal products and blood • Post-authorisation vigilance of medicines and vaccines • Supply of vaccines, medicines and medical products • Actions on falsified and unlicensed medicines, off-label use of medical devices • EU coronavirus certificates • mHealth and data protection Research and development of medicines and vaccines What's happening? When? Find out more European Medicines Agency endorses International Coalition of Medicines Regulatory Authorities and World Health Organization’s statement on supporting healthcare professionals to enhance public confidence in coronavirus vaccines 17 May 2022 The European Medicines Agency (EMA) has endorsed a joint statement by the International

ARCHIVED: This document is archived and is no longer maintained. This Practice Note discusses the implications of the coronavirus (COVID-19) outbreak for the debt capital markets (DCM) and includes practical tips for DCM lawyers. For regular updates of news and analysis on the outbreak relevant to DCM, see: Practice Note: Coronavirus (COVID-19)—implications for Banking & Finance lawyers—Debt capital markets. Coronavirus (COVID-19) Lawyers across the world have been grappling with many common areas of concern in connection with the coronavirus (COVID-19) pandemic. There are a number of areas that are particularly relevant to banking and finance lawyers. For more detail and analysis on these, see Practice Note: Coronavirus (COVID-19) implications for Banking & Finance lawyers, which is updated regularly with news, practical guidance and analysis covering the impact of COVID-19 developments and covers subject areas such as force majeure in lending transactions and execution of documents as well as setting out the implications for different types of banking and finance lawyers. This Practice Note focuses on the implications for DCM and practical steps

UPDATE (30/11/20): The Health Protection (Coronavirus, Restrictions) (All Tiers) (England) Regulations 2020, SI 2020/1374 made on 30 November and in force from 2 December 2020, revoke the Coronavirus Restrictions (No 4) Regs 2020, SI 2020/1200, with the effect that the national lockdown restrictions considered in this Practice Note will cease to have effect at the end of Tuesday 1 December 2020, and not at the end of Wednesday 2 December 2020 as was previously set out in the Coronavirus Restrictions (No 4) Regs 2020, SI 2020/1200. Also on 30 November, the DHSC published guidance on Tier 1: Medium alert, Tier 2: High alert and Tier 3: Very High alert. See News Analysis: New 2 December COVID-19 tiering legislation and guidance published. This Practice Note and Practice Note: Coronavirus (COVID-19)—managing the workplace to 18 July 2021 [Archived] will be updated shortly. UPDATE (26/11/20): On 26 November, the DHSC published a Full list of local restriction tiers by area. See: List of local coronavirus

For information on the coronavirus (COVID-19) job retention scheme (CJRS) generally, see Practice Note: Coronavirus Job Retention Scheme (original version to 30 June 2020) [Archived]. The HMRC guidance for employers: Claim for your employees' wages through the Coronavirus Job Retention Scheme confirms that public authorities are among the entities with a UK payroll who can apply under the scheme. The guidance states that: • the government expects that the scheme will not be used by many public sector organisations, as most public sector employees are continuing to provide essential public services or contribute to the response to the coronavirus outbreak • where employers receive public funding for staff costs, and that funding is continuing, the government expect employers to use that money to continue to pay staff in the usual fashion—and correspondingly not furlough them. This also applies to non-public sector employers who receive public funding for staff costs • organisations who

Law360, London: The Financial Conduct Authority (FCA) has rejected an application by a law firm and a group of hospitality sector trade groups to extend the deadline for business interruption claims linked to the coronavirus (COVID-19) pandemic.

Law360, London: Insurance brokers have less than a year to file claims on behalf of their clients for business losses suffered during the national coronavirus (COVID-19) lockdowns, a law firm warned on 1 April 2025.

For information on the Employment Rights Act 1996 (Coronavirus, Calculation of a Week’s Pay) Regulations 2020 (Week’s Pay Amendment Regs 2020), SI 2020/814 generally, see Practice Note: Coronavirus Job Retention Scheme—right to statutory redundancy and other termination payments [Archived]. The Week’s Pay Amendment Regs 2020, SI 2020/814 set out how a week’s pay is to be calculated in the case of an employee ‘who is, or has been, furloughed’ under the CJRS, for the purpose of calculating certain payments, including the employee’s right to payment under section 88 or 89 of the Employment Rights Act 1996 (ERA 1996). The Week’s Pay Amendment Regs 2020, SI 2020/814 only apply:

ARCHIVED: This Practice Note is archived and is no longer maintained. Coronavirus (COVID-19) Lawyers across the world have been grappling with many common areas of concern in connection with the coronavirus (COVID-19) pandemic. There are a number of areas that are particularly relevant to banking and finance lawyers. For more detail and analysis on these, see Practice Note: Coronavirus (COVID-19) implications for Banking & Finance lawyers, which includes links to news, practical guidance and analysis covering the impact of COVID-19 developments. This Practice Note sets out the key issues which are relevant to real estate finance during the COVID-19 outbreak. For information on general lending issues arising from the COVID-19 outbreak, see Practice Notes: Coronavirus (COVID-19)—implications for lending transactions and Coronavirus (COVID-19)—Banking & Finance frequently asked questions [Archived]. Impact on real estate finance The impact of COVID-19 on the real estate finance (REF) market has gone to the heart of most transactions, affecting property values, rental cashflow and construction timeframes. Lenders and borrowers will need to review their finance

Law360: A group of hospitality and farming businesses have sued the National Farmers Union Mutual Insurance Society Ltd for around £10.5m to cover losses the companies allegedly suffered from closures during the coronavirus pandemic.